In an osteoarthritic knee, inflammatory
cytokines (“bad” proteins) outnumber anti-inflammatory cytokines
(“good” proteins) causing an imbalance resulting in knee pain and
cartilage degeneration.11
The inflammatory proteins IL-1 and TNFa
attack the cartilage11 These “bad” proteins must be stopped
simultaneously to decrease pain and slow cartilage degeneration.
The nSTRIDE® treatment introduces high
levels of “good” proteins (IL-1ra, sIL-1R, sTNF-RI, and
sTNF-RII)10 that is designed to overwhelm and block the inflammatory
cytokines (bad proteins) IL-1 and TNFa.15^ Laboratory, animal and
human studies have shown that nSTRIDE® has decreased pain and slowed
cartilage degeneration, unlike traditional therapies.3^,4,14
While balance is being restored to the
knee, anabolic (building) growth factors (IGF-1 and TGF-.1) are also
introduced for beneficial cartilage health.10 Therefore,
nSTRIDE® creates a novel therapy, which may reduce pain in the knee
joint, may improve joint function and slow the destruction of cartilage.4^
This Autologous Anti-Inflammatory
treatment is provided in a single session in the doctor’s office.